Sensei Biotherapeutics Files 8-K on Financials
Ticker: SNSE · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations
TL;DR
Sensei Biotherapeutics dropped an 8-K on August 5th detailing their financial condition. Check it for the latest numbers.
AI Summary
Sensei Biotherapeutics, Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's financial status. The company is incorporated in Delaware and its principal executive offices are located in Rockville, MD.
Why It Matters
This filing provides investors with crucial, up-to-date information on Sensei Biotherapeutics' financial health and operational performance, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing and does not contain information that inherently increases risk.
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- August 5, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Rockville, MD (location) — Address of Principal Executive Offices
- 240-243-8000 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on August 5, 2025.
Where are Sensei Biotherapeutics' principal executive offices located?
The principal executive offices are located at 1405 Research Blvd, Suite 125, Rockville, MD 20850.
What is the Standard Industrial Classification (SIC) code for Sensei Biotherapeutics, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the Commission File Number for Sensei Biotherapeutics, Inc.?
The Commission File Number is 001-39980.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Sensei Biotherapeutics, Inc. (SNSE).